#-supreme-cellcarta-differentiators-8-705{items-data:[{"text":"Full Olink Portfolio"},{"text":"Multi-Omic Integration"},{"text":"Global Execution"},{"text":"Low Sample Requirements"},{"text":"High-Plex Discovery"}]}#-supreme-cellcarta-faq-12-705{items-data:[{"faq_question":"Which Olink assay is right for my study?","faq_answer":"<p>CellCarta offers the full Olink assay suite:Target 96,Target 48,Flex,Focus,Reveal,and Explore. Target panels are ideal for focused,high-throughput studies quantifying up to 92 proteins from 1 &micro;L of sample. Flex and Focus allow panel customization for defined biomarker hypotheses,while Reveal is designed for broad discovery programs profiling over 1,000 proteins from 4 &micro;L of sample. Explore is well suited for discovery proteomics,investigating 5400+ target proteins from as little as 1 &micro;L of sample. Our scientific team can help you select the right assay for your study design and sample availability.</p>"},{"faq_question":"What does Olink Certified Service Provider status mean for my study?","faq_answer":"<p>CSP status is awarded to laboratories that demonstrate the ability to run Olink workflows to the same standards of quality and consistency as Olink&rsquo;s own facilities. CellCarta holds CSP certification in both Canada and China,and undergoes annual concordance testing and re-certification to maintain that status. For sponsors,this means every Olink assay run at CellCarta comes with a built-in layer of quality assurance and regulatory confidence.</p>"},{"faq_question":"What sample volumes are needed to run Olink assays?","faq_answer":"<p>Olink Explore,Flex,Focus,Target 96,and Target 48 panels require as little as 1 &micro;L of sample,while Olink Reveal requires as little as 4 &micro;L,making Olink PEA technology well-suited for studies involving limited or rare clinical material. Compatible sample types include plasma,serum,cerebrospinal fluid,and more. Our team can advise on sample type and volume requirements during study design.</p>"},{"faq_question":"Can CellCarta support Olink studies as part of a broader multi-omic program?","faq_answer":"<p>Yes. CellCarta can integrate Olink PEA data with outputs from its <a href=\"../../immune-monitoring/\" target=\"_self\">immune monitoring</a>,<a href=\"../../histopathology/\" target=\"_self\">histopathology</a>,<a href=\"../../genomics/\" target=\"_self\">genomics</a>,and <a href=\"../../proteomics/\" target=\"_self\">proteomics</a> platforms,all within a single partner relationship. Data can be brought together and analyzed using CellCarta&rsquo;s proprietary <a href=\"../../../cellengine/\" target=\"_self\">CellEngine&reg;software</a>,enabling deeper biological insights.</p>"}]}#-supreme-cellcarta-service-blocks-9-705{blocks-data:[{"image":"https://cellcarta.com/wp-content/uploads/2026/06/Immunoassay-Services-hero-9.jpg","image_alt":"Immunoassay platform precision biomarker detection laboratory","title":"Immunoassay Platforms","description":"Complement your proteomic data with precision biomarker detection across MSD,Ella,and ELISA platforms.","button_text":"Discover","button_url":"/capabilities/immunoassay-services/","button_target":"_self"},{"image":"https://cellcarta.com/wp-content/uploads/2026/06/Bioinformatics-Services-Hero-166.jpg","image_alt":"Bioinformatics and biostatistics data analysis team","title":"Bioinformatics and Biostatistics","description":"Extract the full value from your datasets with our in-house bioinformatics and biostatistics team.","button_text":"Discover","button_url":"/clinical-trial-services/ai-data-analytics/bioinformatics-biostatistics/","button_target":"_self"},{"image":"https://cellcarta.com/wp-content/uploads/2026/07/CellCarta_-10-2-scaled.jpg","image_alt":"Mass spectrometry proteomics discovery platform","title":"Proteomics","description":"Go broader with mass spectrometry and advanced unbiased discovery across your biological system.","button_text":"Discover","button_url":"/capabilities/proteomics/","button_target":"_self"}]}#-supreme-cellcarta-tab-content-4-705{oxy-supreme-cellcarta-tab-content-content-heading-tag:h3;oxy-supreme-cellcarta-tab-content-content-heading-size:default;oxy-supreme-cellcarta-tab-content-content-body-size:default;tabs-data:[{"tab_title":"Olink Target Panels","content_title":"","content_body":"<p>Quantify up to 92 carefully selected proteins across up to 88 samples simultaneously,using only 1&micro;L of sample.</p>\n<p>The Olink Target 96 and Target 48 panels let you focus on specific disease areas or biological processes,giving your team the targeted data needed to make confident therapeutic decisions.</p>","tab_image":"https://cellcarta.com/wp-content/uploads/2026/07/Image-4.png","image_alt":"Scientist using Olink Target panel instrument for protein biomarker quantification"},{"tab_title":"Olink Flex and Focus","content_title":"","content_body":"<p>Build the panel that fits your study. Flex lets you select up to 21 proteins from a library of approximately 200 validated biomarkers,while Focus deploys custom panels developed by Olink.</p>\n<p>Both options enable absolute quantification and the flexibility to align assay design with your specific biological questions.</p>","tab_image":"https://cellcarta.com/wp-content/uploads/2026/06/Key-Applications-CTA-528.jpg","image_alt":"Scientists collaborating on custom Olink Flex panel design in laboratory"},{"tab_title":"Olink Reveal","content_title":"","content_body":"<p>Explore over 1,000 proteins from as little as 4 &micro;L of sample. With deep coverage across inflammation,immune responses,and oncology,Olink Reveal is built for early discovery programs where casting a wide net is essential to uncovering the right biomarkers.</p>","tab_image":"https://cellcarta.com/wp-content/uploads/2026/07/Olink-Target-Panels-Tab-450.jpg","image_alt":"Scientist using Olink Reveal for broad protein discovery across biological system"},{"tab_title":"Olink Explore","tab_link_enabled":"","tab_link_url":"","tab_link_target":"_self","content_title":"","content_body":"<p>Olink Explore enables large-scale multiplex discovery proteomics,with the capacity to investigate over 5400 analytes simultaneously. This platform is particularly well-suited for the early discovery phase,particularly for uncovering protein targets of interest.</p>","tab_image":"https://cellcarta.com/wp-content/uploads/2026/07/19-IMG_2219-1-scaled.jpg","image_alt":""}]}